Σημειώσεις επεισοδίου
Featuring perspectives from Dr Lindsey Roeker, including the following topics:
• Consensus Approach to optimizing front-line treatment (0:00)
• Emerging role of sonrotoclax (8:39)
• Bruton tyrosine kinase inhibitor monotherapy for older patients; discontinuation (14:48)
• Evolving role of minimal residual disease assessment (19:16)
CME information and select publications
Ιστότοπος: hematologic-oncology.captivate.fm

